Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001814876-25-000007

EVP & CFO sold 69,582 shares at an average $38.55 ($2,682,505)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Coyne Terrance P. · EVP & CFO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-24 Sale : show line 1 in the form 10b5-1 −55,146 $38.67 $2,132,292 669,010 I
2025-11-24 Sale : show line 2 in the form 10b5-1 −10,686 $37.96 $405,645 658,324 I
2025-11-24 Sale : show line 3 in the form 10b5-1 −3,126 $38.67 $120,882 51,634 I
2025-11-24 Sale : show line 4 in the form 10b5-1 −624 $37.96 $23,687 51,010 I
Open-market sales · 69,582 sh · avg $38.55 · $2,682,505
Loading xslF345X05/wk-form4_1764194502.xml…